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Abstract
Increasingly, macroalgae are being recognised as a growth opportunity for functional foods and nutritional
security in the future. Dominating traits of interest are metabolites that function as anti-inflammatories and
are antiproliferative. However, seaweeds from the northern hemisphere dominate this field of research.
Australia has a unique flora of macroalgae, and it is poorly understood which species should be targeted for
cultivation towards food and health markets. Here, six Australian marine macroalgae were selected for
screening of one anti-inflammatory group; n-3 polyunsaturated fatty acids (PUFA). PUFA profiles were
determined using gas chromatography-mass spectrometry and multivariate analysis. Thirty-one fatty acids
(FA) were identified across the six macroalgal species with C16:0 the dominant FA in all samples, variations
across taxa in the saturated FA C10:0, C14:0, C16:0, C18:0 and C20:0 and variations in monounsaturated FA
attributed to C16:1 n-7 and C18:1 n-9. For PUFA profiles, all six species had significantly different n-6/n-3
ratios, while the green seaweed Ulva species possessed the lowest n-6/n-3 ratio of 0.4, along with a 2-fold
higher C18:3 n-3 to C18:2 n-6 content. Ulva sp. was the only species that contained docosahexaenoic acid.
Extracts of both the Ulva sp. and Hormosira banksii showed selective cytotoxicity towards a human pancreatic
cancer cell line, while the nonpolar extracts of all six algae species strongly inhibited production of the
inflammatory-mediator nitric oxide.
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Abstract Increasingly macroalgae are being recognized as a growth opportunity for functional 
foods and nutritional security in the future. Dominating traits of interest are metabolites that 
function as anti-inflammatories and are antiproliferative. However seaweeds cultivated in the 
northern hemisphere dominate this field of research. Australia has a unique flora of macroalgae 
and it is poorly understood which species should be targeted for cultivation towards food and 
health markets. Herein, six Australian marine macroalgae were selected for screening of one anti-
inflammatory group; n-3 polyunsaturated fatty acids (PUFA). PUFA profiles were determined 
using gas chromatography - mass spectrometry and multivariate analysis. Thirty-one fatty acids 
(FA) were identified across the six macroalgal species with C16:0 the dominant FA in all samples, 
variations across taxa in the saturated FA C10:0, C14:0, C16:0, C18:0 and C20:0 and variations in 
monounsaturated FA attributed to C16:1 n-7 and C18:1 n-9. For PUFA profiles, all six species had 
significantly different n-6/n-3 ratios, while the green seaweed Ulva sp. possessed the lowest n-6/n-
3 ratio of 0.4, along with a 2-fold higher C18:3 n-3 to C18:2 n-6 content. Ulva sp. was the only 
species that contained docosahexaenoic acid. Extracts of both the Ulva sp. and H. banksii showed 
selective cytotoxicity towards a human pancreatic cancer cell line, while the non-polar extracts of 
all six algal species strongly inhibited production of the inflammatory-mediator nitric oxide. 
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Macroalgae are a large and growing multi-billion dollar food and biotechnology industry (FAO 
2012; Mazarrasa et al. 2013). Increasingly they are being recognised as a rich source of 
biologically active metabolites for utilisation in functional foods, nutritional supplements and/or 
pharmaceuticals (Stengel et al. 2011). This is due to important functional roles of these metabolites 
in a range of biological processes including cell mediation and immune responses (Warude and 
Joshi 2006; Rubio-Rodríguez et al. 2010; Calder and Yaqoob 2009; Kumari et al. 2010; Mohamed 
et al. 2012; Smit 2004). Research in medical and health applications of seaweed metabolites now 
dominate the publication of phycology related scientific literature (Winberg et al. 2014). There is 
particular promise for chronic inflammatory diseases and cancers of the digestive system (Vo et al. 
2012; O'Sullivan et al. 2010) (Fig. 1). Metabolites that contribute to anti-inflammatory function 
include essential polyunsaturated fatty acids (PUFA) such as alpha-linolenic acid (ALA, C18:3 n-
3) that cannot be synthesised by humans and therefore must be obtained from dietary sources, as 
well as the essential n-3 long-chain PUFA such as eicosapentaenoic acid (EPA, C20:5 n-3), 
docosapentaenoic acid (DPA, C22:5 n-3), and docosahexaenoic acid (DHA, C22:6 n-3) (Glick and 
Fischer 2013). These PUFA function as competitors to the pro-inflammatory metabolism of 
linoleic acid (LA, C18:2 n-6) as the parent fatty acids (FA) for the pro-inflammatory metabolism 
of the n-6 PUFA arachidonic acid (AA). n-6 AA is a biosynthetic precursor to prostaglandin E2 
(PGE2) and leukotriene B4 (LTB4) inflammation pathways and inflammatory eicosanoids such as 
prostaglandins and leukotrienes (Glick and Fischer 2013). Conversely, n-3 PUFA can be 
enzymatically converted to bioactive autacoids with inflammatory-resolving properties that 
compete with and offset inflammation status (Zhang and Spite 2012; Jaswir and Monsur 2011). 
Thus, a reduced ratio of n-6/n-3 PUFA is considered important to suppress chronic inflammatory 
disease triggered by a higher intake of n-6 PUFA in modern diets (Meyer et al. 2003; Simopoulos 
2002). The pathogenesis of diseases include cardiovascular disease, cancer and other inflammatory 
disorders (Simopoulos 2002; Grenon et al. 2011). Thus, a greater consumption of long chain n-3 
FA may offer protective effects by suppressing proinflammatory activity (Grenon et al. 2011; 
Harper and Jacobson 2001).  
 
McCauley et al., J App Phyc 
3 
 
Fig. 1 The distribution of published research effort in terms of reference to macroalgae and each of 
the health application terminologies (e.g. anti-inflammatory) as found in Google Scholar database 
of scientific literature. 
Of the n-3 PUFA, ALA is predominately found in vegetable oils and nuts, and EPA and DHA in 
marine fish and fish oils (Meyer et al. 2003). Conversion of ALA to EPA and DHA is limited and 
therefore dietary consumption of these two long-chain PUFA is highly recommended (Goyens et 
al. 2006; Burdge and Wootton 2002). The proposed health benefits of n-3 PUFA have led to 
increased demand for their use as animal feed additives to promote bioaccumulation, and for direct 
human consumption (Mansour et al. 2005; Nettleton 1995). Because of increasing costs and 
availability of fish derived PUFA from fish oil, there is a need to develop alternative sources. 
Marine algae are primary producers of PUFA that fish obtain through trophic bioaccumulation 
(Sijtsma and de Swaaf 2004; Guschina and Harwood 2006) and represent a promising new PUFA 
source. This presents an opportunity to target whole seaweed as a food and animal feed, not only 
for trace elements like iron and iodine, but also for lipids that are deficient in the Western diet 
(Lucas 2006; Meyer et al. 2003). However, a challenge remains to understand which species 
contain optimal PUFA profiles that could balance current dietary practice and the profile 
variablility between taxa.  
Inflammation is a complex and multifactorial network of chemical signals (Coussens and Werb 
2002). Nitric oxide (NO), an important biological mediator, is one chemical molecule that is 
generated by the enzyme inducible nitric oxide synthase (iNOS) during immune and inflammatory 
responses (Coleman 2001). Elevated and chronic NO production, as seen in persistent 
inflammatory disorders is associated with dysregulation of signaling events and immune response 
resulting in cell and tissue injury (Cross and Wilson 2003) and subsequently cancer (Coussens and 
Werb 2002). Suppression of NO production has been observed with n-3 PUFA via inhibition of 
iNOS (Ohata et al. 1997). Further anti-inflammatory compounds are diverse across fractions of 
metabolites and function in different inflammation pathways including iNOS, cyclooxygenase 
(COX) and reactive oxygen species (ROS) metabolism (Vo et al. 2012). For algae, these fractions 
include both non-polar and polar extracts and have been shown to function differently across 
assays for these different inflammatory processes. For example non-polar algal extracts include 
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phlorotannins that have been shown to reduce the production of NO and reduce edema, along with 
anti-inflammatory PUFA, carotenoids, terpenoids and xanthophylls (Jaswir and Monsur 2011). 
The metabolic profiles and biological activity of extracts from northern hemisphere macroalgal 
species have been well described including both genetic and spatial/temporal variations (Holdt and 
Kraan 2011; Schmid et al. 2014). However in Australia, which is a macroalgal biodiversity hotspot 
(Womersley 1990) with high species richness and endemism of benthic flora (Phillips 2001), a 
legacy of little use in food has resulted in a paucity of knowledge of Australian species with the 
potential for applications in health. Australia has been seeking to grow its aquatic production 
industries, and macroalgae have been selected based on existing market (colloid) or 
bioremediation potential, but little has been done to select species based on the potential 
applications in targeted health markets. Herein, six Australian macroalgal species were screened 
for their FA profiles and organic extracts of varying polarity from each species were evaluated for 
both anti-inflammatory activity and selective cytotoxicity for prioritising candidates from a human 
health context.  
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Materials and Methods  
Collection Macroalgal species for biological assessment and fatty acid profiling were collected 
seasonally from a number of locations along the South East coast of New South Wales (NSW) 
Australia. For biological assessment, the algal species: Hormosira banksii (Turner) Decaisne, 
Phyllospora comosa (Labillardière) C.Agardh and Ecklonia radiata (C.Agardh) J.Agardh were 
collected from Gerringong, Solieria robusta (Greville) Kylin was collected from Callala Beach 
and Myriogloea sciurus (Harvey) Kuckuck ex Oltmanns was collected from Manyana. Samples 
were cleaned from epiphytes and sand and dried (70 °C), pulverized and vacuumed sealed until 
analysis. For fatty acid profiling fresh samples were collected, cleaned and freeze-dried 
immediately prior to analysis. The Ulva sp. (filamentous morphology) used herein was obtained 
from culture, kept and maintained for several months (Table 1). 
Table 1 Summary of samples collected seasonally from various locations along the South East 
cost of NSW Australia, including species, phylum, order, collection site (latitude & longitude) 
and/or date of harvest or collection. 
Extraction and Transesterification of Fatty Acids Lipids were extracted using the method of Folch 
et al. (1957) with modifications by Kumari et al. (2010). In brief, 250 mg dry weight was extracted 
with 3x3 mL of chloroform/methanol (2/1, v/v) with 0.001% butylated hydroxytoluene (BHT) by 
vortexing (~1 min) and centrifugation (3000 rpm, RT, 15 mins). Combined supernatants were 
washed with 2 mL of Milli-Q water (3000 rpm, RT, 5 mins). The extract was evaporated to 
dryness in pre-weighed 9 mL Teflon lined screw top glass culture tubes under a stream of 
nitrogen. Crude lipid extracts were transesterified according to the method of Lepage and Roy 
(1986) with added BHT (0.01% w/v). Extractions performed in triplicate using homogenized 
powder of the whole algae sample. 
FA Analysis FA were analysed by flame-ionization GC (model GC-17A; Shimadzu, Rydalmere, 
NSW, Australia) using a 50 m x 0.25 mm internal diameter capillary column. One microliter of the 
transesterified sample was auto-injected into the column, and individual FA were quantified using 
the Shimadzu analysis software (Class-VP 7.2.1 SP1). FA were identified by comparison with 
known standards (Nu-chek or Sigma, Sydney, Australia). Heneicosanoic acid (0.2 mg.mL-1 in 
toluene) was used as an internal standard for quantification and samples were analysed in 
triplicate. Relative compositional data is represented as molar % composition of total FA taking 
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into account the molecular weight of the identified FA. Quantified data is represented as mg.g-1 
dry weight (d.w.). 
Biological Assays For biological assays samples were dried at 70 °C for 48 h, pulverised to a fine 
powder and extracted in a 1:1 dichloromethane (DCM): methanol solution using a modified 
version of Ebada et al. (2008). The crude extract was partitioned into DCM, ethyl acetate (EtOAc) 
and butanol (BuOH) and organic phases evaporated to dryness. Stock solutions were dissolved in 
100% dimethyl sulfoxide (DMSO) (10 mg.mL-1) and diluted with culture medium to obtain testing 
concentrations of 100 ug.mL-1 in 1% DMSO.  
Extracts were assessed for cytotoxicity at 100 μg.mL-1 on human pancreatic carcinoma (MIA-
PaCa-2) cell line, Abelson murine leukemia virus-induced tumor macrophage (RAW 264.7) and 
wild-type murine embryo fibroblasts cell lines (WT-MEF). Cytotoxicity was determined as % 
inhibition of cell proliferation, measured by colorimetric markers (MTS Reagent) of 
dehydrogenase enzyme activity, relative to controls (24-48 hr incubations) (McCauley et al. 2013). 
RAW 264.7 macrophage cells were either pre- or co–incubated with lipopolysaccharides (LPS) (1 
μg.mL-1) and the extracts (100 μg.mL-1) for 24 hrs (37 ºC, 5% CO2), including controls.  
The quantity of nitrite (NO2
-) accumulated in the supernatant, as a measure of positive 
inflammation response (NO production), was measured by mixing equal volumes of supernatant 
with Griess reagent (1% sulphanilamide and 1% N-(1-Naphthyl)ethylenediamine dihydrochloride 
solution). After 10 mins incubation at rt absorbance was measured. NO2
- concentrations were 
calculated using a standard curve. NO inhibition was determined as % of LPS induced 
inflammatory controls (Shanmugam et al. 2008). 
Statistical Analysis Multivariate FA profiles across macroalgal taxa were visualised in 
multidimensional scaling (MDS) plots using Euclidean distances due to a large number of zeros in 
the data. Apparent groupings were tested using Analysis of Similarity (ANOSIM) with PRIMER-
E V6 software (Plymouth Marine Laboratories (Clarke and Gorley 2006). Data was analysed in 
both untransformed raw format, to compare the relative abundance of different FA to chemical 
profiles differences, as well as presence/absence transformation (either a 1 or a 0 value) to 
compare the overall FA composition. This is a rapid method to objectively identify key groups of 
or specific FA that differ across taxa, which could then be tested in univariate analyses. 
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Identification of the FA or groups of FA that contributed most to differences between taxa was 
done using the PRIMER-E Similarity Percentages Analysis (SIMPER) tool in PRIMER-E.  One-
way Anova, Tukey’s multiple comparisons test, and Students t-Test were used to determine 
significantly different means for individual fatty acids of interest using GraphPad Prism version 
6.00, GraphPad Software, La Jolla California USA, www.graphpad.com. 




Key differences in FA composition across species A total of 31 fatty acids were identified across 
the six algal species (Table 2). The highest number of FA (26) were identified in the both the 
brown algae Hormosira banksii and the green algae Ulva sp.; followed by the three brown algal 
species with 18 FA identified in both Myriogloea sciurus and Phyllospora comosa, 15 in Ecklonia 
radiata; and the lowest number (14 FA) in the lipid extract of the red algae Solieria robusta.  
Table 2 FA composition of six Australian macroalgal species. Data presented as % molar area of 
total FA. Means with different letters are significantly different (p < 0.05). 
Key differences in abundance across species Analysis of the quantified fatty acid data (mg.g-1 d.w. 
whole biomass) showed significant differences were observed between phyla (analysis of 
similarity, R < 0.9, p < 0.01) and between species within the Ochrophyta (analysis of similarity R 
< 0.9, p < 0.02) (Fig. 2). Transformation of the data to reduce the effect of abundance indicated 
that phyla differences are significantly distinct in terms of the composition of fatty acid profiles 
(analysis of similarity R < 0.9, p < 0.01). However, species differences were not significant within 
the Ochrophyta (p = 0.10) despite some evident clustering (data not shown).  
Fig. 2 Multivariate Dimentional Scaling plot comparing similarities of species fatty acids profiles 
(mg.g-1 d.w.). Samples are from triplicate lipid extracts of six Australian native and endemic 
macroalgae. Data is untransformed. 
SIMPER analysis revealed that C18:0, C20:0 and C22:0 were the three main SFA that determined 
species variation in terms of both composition and abundance (Fig. 2). C18:0 is most abundant in 
S. robusta followed by Ulva sp. along with higher C20:0 content for the latter species. C22:0 was 
not present in E. radiata or S. robusta and was most abundant in H. banksii. In regards to PUFA, 
SIMPER analysis showed that species variations were primarily due to C18:2 n-6 (LA), C18:3 n-3 
(ALA), C20:4 n-6 (AA), C20:3 n-3 (ETA) and C20:5 n-3 (EPA). Oleic acid (C18:1 n-9) was most 
abundant in H. banksii and M. sciurus with trace amounts in S. robusta. Ulva sp. showed the 
highest abundance of essential ALA (C18:3 n-3) as a proportion of total significantly identified 
PUFA. This was followed by H. banksii, which had the second highest ALA content along with a 
significantly higher proportion of AA (C20:4 n-6) and EPA (C20:5 n-3). 
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On a molar % basis, palmitic acid (C16:0) was the predominant FA in all six samples ranging from 
20.5% in the Ulva sp. to more than double that amount (46.3%) in M. sciurus. The second most 
dominant FA was oleic acid (C18:1 n-9) for E. radiata, M. sciurus and H. banskii (20.2, 19.7 and 
18.7% resp.); AA (C20:4 n-6) for P. comosa and S. robusta (21.2 and 20.6% resp.); and ALA 
(18:3 n-3) for Ulva sp (12.2%). The third most abundant FA ranging from 9.4-17.1% differed for 
each species from saturated FA for M. sciurus and S. robusta (myrisitic acid (C14:0) and capric 
acid (C10:0) resp.); to MUFA for E. radiata (C16:1 n-7), P. comosa and Ulva sp. (C18:1 n-9) and 
AA (C20:4 n-6) for H. banksii. The latter species also had a relatively high abundance of other 
desirable FA such as ALA, LA and EPA (7.4%, 5.5% and 5.8% resp.), identifying this as a key 
species to pursue further. 
Along with high C16:0, S. robusta was characterised by a high C18:0 and C10:0 SFA, the latter 2 
to 5-fold greater than for all other species, coupled with low oleic acid (C18:1 n-9) levels (Fig. 3). 
Ulva sp. was characterised by a high proportion of C16:0, oleic acid (C18:1 n-9) and C20:0 SFA, 
and moderate, essentially equivalent palmitoleic (C16:1 n-7) levels (Fig. 3). Conversely, all four 
Ochrophyta species were characterised by moderate C14:0 and low C18:0 SFA content, instead 
dominated by a high proportion of oleic acid (C18:1 n-9), 10-fold greater than S. robusta and 2 to 
3-fold greater than Ulva sp.  
The predominant PUFA across all six species were the n-3 FA, ALA (C18:3 n-3) and EPA 
(C20:5 n-3) and the n-6 FA LA (C18:2 n-6) and AA (C20:4  n-6) (Fig. 3). The most desirable 
ALA to LA ratio was observed for the Ulva sp. with a 2-fold higher ALA content compared to 
LA; followed by H. banksii with 1.3-fold higher ALA than LA; and then conversely P. comosa 
showing a 2-fold higher LA to ALA content. AA (C20:4 n-6) was the second most abundant FA 
for S. robusta and P. comosa, and third most abundant for H. banksii, and lowest in the Ulva sp. 
The DHA precursor, EPA (C20:5 n-3) was highest in H. banksii (5.8%), followed by Ulva sp. 
(5.3%) and P. comosa (3.9%). H. banksii also showed traces of eicosatrienoic acid (ETA; C20:3 n-
3), while the long-chain n-3 DHA (C22:6 n-3) was only detected in the green macroalgae Ulva sp., 
albeit in trace amounts (0.5%).  
The lowest ratio of n-6/n-3 PUFA was observed for the Ulva sp. (0.4), with the ratio ranging from 
1.5-3.8 for the four brown species, and 5-fold higher for the red seaweed S. robusta (15.7). 
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Fig. 3 Key differences in fatty acid content (mg.g-1 d.w.) across the six Australian marine 
macroalgae of both total and individual SFA, MUFA and PUFA 
Anti-inflammatory activity A qualitative summary of the percent reduction of NO production in 
LPS stimulated macrophage RAW 264.7 cells relative to controls (Table 3), showed a significant 
reduction in NO production across almost all of the 18 extracts. The order of activity was greatest 
in the non-polar, lipid-rich dichloromethane (DCM) extracts (>76% activity for all species), 
followed by the intermediate polarity ethyl acetate (EtOAc) extracts (>50% activity for all species 
except H. banksii), with the lowest activity observed in the polar butanol (BuOH) extracts (Table 
3). Although the non-polar DCM extracts were the most active, those of P. comosa and S. robusta 
also exhibited high cytotoxicity towards all three cell lines investigated, including the normal 
(WT-MEF) cell line. In general, the EtOAc extracts, in particular P. comosa, M. sciurus and Ulva 
sp. showed promising NO reducing activity, coupled with low toxicity towards the normal cell 
line, with the exception of M. sciurus. 
Cytotoxicity A qualitative summary of 24 and 48 hr cytotoxicity data for three cell lines is 
presented in Table 3. The non-polar DCM extracts of P. comosa and S. robusta showed high 
cytotoxicity (>76%) across all cell lines investigated (i.e. macrophage RAW 264.7, wild-type 
murine embryonic fibroblast WT-MEF and human pancreatic carcinoma MIA-PaCa-2 cell lines). 
In addition to strongly reduced NO production, the DCM and EtOAc extracts of Ulva sp. showed 
preferential cytotoxicity towards the MIA-PaCa-2 human pancreatic carcinoma cell line. The 
EtOAc extract of H. banksii showed the greatest selectivity towards the pancreatic cancer cell line, 
along with a moderate reduction in NO production.  
Table 3 Cytotoxicity and anti-inflammatory activity (via inhibition of nitric oxide (NO)) of 18 
algal extracts from six macroalgae. Data are presented as % activity at 100 μg.mL-1 from two 
independent trials done in duplicate.  
Discussion  
Herein this study presents key differences from the screening process of six taxa of Australian 
macroalgae for prioritizing future work towards anti-inflammatory applications. To this end, 
consistent anti-inflammatory activity was observed for all taxa in terms of decreased NO 
production, predominantly in the DCM and EtOAc extracts. However, the species were highly 
diverse in the abundance of FA, with approximately 30% more types of FA in Ulva sp. and H. 
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banksii than in the other taxa. The highest abundance of PUFA was in H. banksii and the 4th 
lowest in Ulva, while the more preferable n-6/n-3 ratio and LA/ALA ratio was found for Ulva. In 
addition, the selective cancer cell toxicity was greatest for Ulva and H. banksii (Table 4). 
Table 4 Summary of key differences from the screening process of six taxa of Australian 
macroalgae for prioritizing future work towards anti-inflammatory applications with a focus on 
PUFA content. 
With the exception of the well-studied green macroalgae genus Ulva (Floreto et al. 1993; 
Alamsjah et al. 2008; Ortiz et al. 2006) the five other macroalgal species described herein have 
been studied in other contexts such as their protein, trace element and carbohydrate content 
(Edmonds and Francesconi 1981), but rarely in terms of their FA profiles and anti-inflammatory 
activity. Investigation of a different sample of P. comosa from South Eastern Australia has been 
reported by us previously with an analogous profile to that described here (Zivanovic and Skropeta 
2012). The FA profile of a red seaweed belonging to the genus Solieria has been described as 
dominated by C16:0 and C20:5 n-3, with the EPA content differing from our results (Bert et al. 
1991).  
Apart from palmitic acid (C16:0), which was the dominant FA in all six species and is consistent 
with other macroalgae (Schmid et al. 2014; Zivanovic and Skropeta 2012; Holdt and Kraan 2011) 
the remainder of the FA profiles were significantly different for the three phyla investigated 
herein. This is consistent with previous reports where FA signatures have been used to distinguish 
taxonomic groups up to the family level but not at the level of species (Galloway et al. 2012; 
Kumari et al. 2013).  
From the four Ochrophyta species, the two fucales species showed comparable total SFA, MUFA 
and PUFA levels (Kumari et al. 2013; Khotimchenko et al. 2002). M. sciurus (Order Ectocarpales) 
and E. radiata (Order laminariales) reported herein however showed reduced levels of total PUFA 
when compared to similar species previously reported from the same order (Khotimchenko et al. 
2002; Kumari et al. 2013). Overall, the four Ochrophyta species were characterised by high C16:0, 
moderate C14:0 and low C18:0 SFA; the highest levels of oleic acid, particularly for E. radiata, 
M. sciurus and H. banksii; but varying PUFA profiles and abundance with H. banksii and P. 
comosa containing amongst the highest amounts of the long-chains PUFA AA (C20:4 n-6) and 
EPA (C20:5 n-3) and M. sciurus and E. radiata containing the lowest abundance of PUFA of all 
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the six species. The dominant C18:1 n-9, C20:4 n-6 and C20:5 n3 is consistent with average 
abundances reported for the Class Phaeophyceae (Kelly and Scheibling 2012).  
The red seaweed S. robusta (order Gigartinales) was characterized by the highest amount of capric 
acid (C10:0), along with other SFA in high amounts (C16:0 and C18:0); the lowest abundance of 
MUFA; and a PUFA profile comprised almost entirely of AA, consistent with other reports that 
Rhodophyta are dominated by the presence of C20 PUFA (Kelly and Scheibling 2012; Graeve et 
al. 2002). EPA (C20:5 n-3) levels herein were comparable to results reported for a number of 
species belonging to the order Gigartinales from the Senegalese coast  by Aknin et al (1990). 
However, EPA has been reported in higher amounts in other red algae (Order Gigartinales) from 
the Pacific coast of North California (Khotimchenko et al. 2002). In terms of total SFA, MUFA, 
PUFA, the results obtained were comparable to reported values for Rhodophyta species (Kumari et 
al. 2013). On the other hand, the green seaweed Ulva sp. was characterized by a high proportion of 
longer chain SFA such as C20:0; higher amounts of oleic (C18:1 n-9) (cf. to C18:0) and equivalent 
amounts of palmitoleic acid (C16:1 n-7), both dominant MUFA; and  a PUFA profile rich in ALA 
(C18:3 n-3), the highest proportion of all species, LA (C18:2 n-6) and EPA (C20:5 n-3), with the 
LA and ALA content a defining feature of Chlorophyta species (Kelly and Scheibling 2012). 
The species differences in PUFA composition contributed to significantly different n-6/n-3 ratios 
for each of the six species investigated. With the exception of S. robusta, the n-6/n-3 ratios were 
between 0 and 4, which is consistent with previous reports for the FA profiles of diverse species of 
macroalgae (Schmid et al. 2014; van Ginneken et al. 2011; Colombo et al. 2006). As a desirable 
ratio for human health is around 1 (Meyer et al. 2003; Simopoulos 2002), this further highlights 
the potential health benefits available from large-scale cultivation of macroalgae such as Ulva sp. 
as a source of beneficial PUFA with n-6/n-3 < 1 along with a ratio of LA/ALA <1. 
It is important to note that chemical composition, including FA profiles can exhibit clear seasonal 
and within plant variation, particularly in regards to total lipid content rather than the lipid profile 
(Gosch et al. 2014; Black 1954; Stengel et al. 2011). Thus any future algal cultivation would need 
to consider cultivation conditions that best enhance PUFA profiles for target algal species and total 
lipid content, along with rigorous measures to ensure quality control. 
Biological evaluation of the organic extracts generated from oven dried biomass of all six species 
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was also performed. All 18 extracts exhibited a degree of inhibition of production of the 
inflammatory mediator NO, whereby the activity followed the order: non-polar extracts > 
intermediate polarity extracts > polar extracts. Non-polar (DCM) extracts are the FA-rich fraction 
and also known to contain phenolic compounds as well as pigments; all of which have unique 
functions in inflammatory metabolism (Jaswir and Monsur 2011; Lee et al. 2013). Interestingly, n-
3 PUFA have been reported as modulators of the activity of nitric oxide synthase (NOS) 
(Radosinska et al. 2011), one of the primary enzymes involved in NO production. MUFA 
derivatives have also been isolated from Ulva lactuca which act as activators of the cytoprotective 
Nrf2 –ARE pathway (Wang et al. 2013), linked to suppression of inflammatory responses (Chen 
and Kunsch 2004). Furthermore, the brown alga Eisenia bicyclis (order Laminariales) was 
evaluated for anti-inflammatory activity via inhibition against LPS-induced NO and other 
inflammatory mediators in RAW 264.7 cells as in this study. Similar to our findings, the activity 
was found to be greatest in the non-polar DCM extract (Jung et al. 2013). In their case the activity 
was attributed to fucosterol, which has also been shown to suppress production of NO and the 
inflammatory cytokines TNF- and IL-6 in the brown alga Undaria pinnatifida (order 
Laminariales) (Yoo et al. 2012). 
Anti-inflammatory activity has been reported for a range of other algal metabolites isolated from 
non-polar and DCM extracts including the chromene sargachromanol G from the Korean brown 
alga Sargassum siliquastrum (order Fucales) (Yoon et al. 2012); halogenated compounds from the 
Malaysian red alga Laurencia snackeyi (Vairappan et al. 2013) and the porphyrin derivatives, 
pheophorbide a and pheophytin a, along with the xanthophyll fucoxanthin, from the edible brown 
alga Saccharina japonica (order Laminariales) (Islam et al. 2013). Other bioactive algal 
metabolites isolated from non-polar extracts include cytotoxic, antibacterial linear 
sesquiterpenoids from the green alga Penicillus capitatus (class Ulvophyceae, order Bryopsidales) 
(Paul and Fenical 1984); antibacterial labdane diterpenoids from Ulva fasciata  (Chakraborty et al. 
2010); and antiatherosclerotic phytosterols from the brown alga Sargassum fusiforme (order 
Fucules) (Chen et al. 2014).  
Most extracts displayed minimal toxicity to the cell lines investigated. However, six algal extracts 
showed high cytotoxicity towards a human pancreatic cancer cell line, with the EtOAc extracts of 
Ulva sp. and H. banksii showing the greatest selectivity with no toxicity towards a normal murine 
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cell line. Marine algae are well known as rich sources of unique, structurally diverse, biologically 
active natural products with a range of reported activities including anticancer, antiviral, 
antibacterial, antifungal and immunomodulating activities (Gupta and Abu-Ghannam 2011; Brown 
et al. 2014; Mohamed et al. 2012). In particular, a number of promising anticancer compounds 
have been isolated from algae including the anti-mitotic stypoldione from the brown alga 
Stypodium zonale and the cytotoxic dehydrothysiferol from the red alga Laurencia viridis (Brown 
et al. 2014). Thus, further investigation to identify the active component of the selectively 
cytotoxic extracts is needed. 
In summary, six Australian macroalgal species were evaluated for their FA composition and anti-
inflammatory activity. From these studies, the green seaweed Ulva sp. emerged with one of the 
highest number of different FA identified and exhibited a favourable n-6/n-3 ratio of 0.4, as well 
as a 2-fold higher ALA (C18:3n-3) to LA (C18:2n-6) content. Ulva was also the only species to 
contain the desirable long-chain n-3 DHA with the lowest amounts of AA. The brown seaweed H. 
banksii was also of interest in terms of its rich FA profile with the highest EPA and ETA content 
of all six species, the latter known to have anti-inflammatory properties (Calder 2009), the second 
lowest n-6/n-3 ratio of 1.5, the second best ALA to LA ratio of 1.3:1, although accompanied by 
the highest abundance of AA. These results have implications in product development by 
highlighting target species such as Ulva sp. and H. banksii with both desirable n-3 PUFA and 
biological activity profiles. 
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List of Tables 
Table 1 Summary of samples collected seasonally from various locations along the South East 
cost of NSW Australia, including species, phylum, order, collection site (latitude & longitude) 
and/or date of harvest or collection. 
Species  Phylum Order Location Latitude Longitude Date 
Ecklonia radiata♮ Ochrophyta Laminariales Jervis Bay 150.7347 35.0653 10/04/2014 
Hormosira banksii♮ Ochrophyta Fucales Jervis Bay 150.7347 35.0653 10/04/2014 
Phyllospora comosa♮ Ochrophyta Fucales Jervis Bay 150.7347 35.0653 10/04/2014 
Solieria robusta♮ Rhodophyta Gigartinales Jervis Bay 150.7347 35.0653 10/04/2014 
Ecklonia radiata Ochrophyta Laminariales Gerringong 150.8271 34.7423 04/04/2012 
Hormosira banksia Ochrophyta Fucales Gerringong 150.8271 34.7423 04/04/2012 
Phyllospora comosa Ochrophyta Fucales Gerringong 150.8271 34.7423 04/04/2012 
Solieria robusta Rhodophyta Gigartinales Callala Beach 150.6899 35.0086 29/04/2012 
Myriogloea sciurus♭ Ochrophyta Ectocarpales Manyana 150.5167 35.2500 01/11/2012 
Ulva sp. ♯ Chlorophyta Ulvales Cultivated# 150.5167 35.2500 16/05/2014 
♮Fresh samples collected and immediately freeze-dried for species fatty acid profiling; ♭Freeze-
dried sample prepared from frozen voucher sample; #Species name withheld; species maintained in 
culture.  
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Table 2 FA composition of six Australian macroalgal species. Data presented as % molar area of 
total FA. Means with different letters are significantly different (p < 0.05). 
Fatty Acid Ochrophyta Rhodophyta Chlorophyta 
% Molar Area E. radiata M. sciurus. H. banksii P. comosa S. robusta Ulva sp. 
10:0 8.5b 4.3ad 3.6a 5.3ad 17.1c 5.6d 
11:0 0.0 0.0 0.0 0.0 0.0 0.1 
12:0 0.0 0.0 0.0 0.0 0.0 0.7 
14:0 10.7a 9.4a 4.8b 7.5d 1.0c 3.1b 
14:1 n-7 0.0a 0.0a 0.0a 0.0a 0.0a 2.5b 
15:0 0.6 0.6 0.6 0.5 0.0 0.6 
15:1 0.2 0.3 0.1 0.9 0.0 0.5 
16:0 27.9b 46.3a 27.5b 25.4c 26.4bc 20.5d 
16:1 n-7 11.4a 6.5cd 3.7b 6.1cd 9.9ae 9.1e 
17:0 0.0 0.2 0.2 0.1 0.0 1.2 
17:1 n-7 0.0a < 0.1a 0.1a 0.2a 3.5b 0.6a 
18:0 1.8a 3.8b 1.5a 1.7a 16.7c 6.6d 
18:1 n-9  20.2a 19.7a 18.7a 13.7b 1.5c 10.6d 
18:1 n-7 0.0a 0.0a 0.3ac 0.0a 2.3b 1.9bc 
18:2 n-6 (LA) 3.0a 3.7ab 5.5bc 7.0c 0.2d 5.4b 
18:3 n-6 0.5 < 0.1 0.1 0.6 0.0 0.6 
18:3 n-3 (ALA) 1.8a 1.9a 7.4b 3.9d 0.1a 12.2c 
20:0 2.4b 1.2b 1.5b 1.8b 2.6b 5.8a 
20:1 n-9 0.0 0.1 0.1 0.0 0.0 0.0 
20:2 n-6 0.0 0.0 0.8 0.0 0.0 0.0 
20:3 n-6 0.0 0.0 1.3 0.7 0.1 0.1 
20:4 n-6 (AA) 8.7d 1.3b 13.2 c 21.1a 20.6a 0.8b 
20:3 n-3 (ETA) 0.0 0.0 0.7 0.0 0.0 0.0 
20:5 n-3 (EPA) 2.3acd 0.9a 5.8b 3.9de 0.9a 5.3be 
22:0 0.0 0.3 1.3 0.1 0.0 0.3 
22:1 n-9 1.2 0.0 1.7 0.0 0.0 0.3 
22:2 n-6 0.0 0.0 0.1 0.0 0.0 0.0 
22:5 n-6 0.0 0.0 < 0.1 0.0 0.0 0.1 
24:0 0.0 0.0 0.1 0.0 0.0 0.0 
22:6 n-3 (DHA) 0.0 0.0 0.0 0.0 0.0 0.5 
24:1 n-9 0.0 0.0 0.0 0.0 0.0 0.6 
Σ SFA 50.7a 65.5b 40.6c 42.0c 60.8b 47.4a 
Σ MUFA 33.0b 26.7ac 24.6cd 20.8def 17.2e 26.0f 
Σ PUFA 16.3d 7.8c 34.8a 37.2a 22.0b 26.5b 
n-6/n-3 3.0a 1.8b 1.5c 3.8d 15.7e 0.4f 
LA/ALA 1.7 1.94 0.74 1.8 2 0.44 
AA: arachidonic acid; ALA: alpha-linolenic acid; DHA: docosahexaenoic acid; EPA: 
eicosapentaenoic acid; ETA: eicosatrienoic acid; LA: linoleic acid. 
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Table 3 Cytotoxicity and anti-inflammatory activity (via inhibition of nitric oxide (NO)) of 18 
algal extracts from six macroalgae. Data are presented as % activity at 100 μg.mL-1 from two 
independent trials done in duplicate. 
Species Extract RAW 264.7 WT MEF MIA PaCa-
2 
%  NO 
E. radiata DCM + - - +++ 
 EtOAc - - - ++ 
 BuOH + - - - 
M. sciurus DCM - - - +++ 
 EtOAc - + - +++ 
 BuOH - - - ++ 
H. banksii DCM - + - +++ 
 EtOAc - - +++ + 
 BuOH + - - - 
P. comosa DCM +++ +++ +++ +++ 
 EtOAc - - - +++ 
 BuOH - - - - 
S. robusta DCM +++ +++ +++ +++ 
 EtOAc nt nt +++ ++ 
 BuOH + - - + 
Ulva sp. DCM + + +++ +++ 
 EtOAc + - +++ +++ 
 BuOH - - - + 
Key: (-) 0 - 24% activity; (+) 25 - 50%; (++) 51 - 75%; (+++) 76 - 100% activity; (nt); not tested, 
no available extract. Investigated cell lines include human pancreatic carcinoma (MIA-PaCa-2), 
Abelson murine leukemia virus-induced tumor macrophage (RAW 264.7) and wild-type murine 
embryo fibroblasts cell lines (WT-MEF)  
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Table 3 Summary of key differences from the screening process of six taxa of Australian 
macroalgae for prioritizing future work towards anti-inflammatory applications with a focus on 














Ecklonia radiata  YES    YES 
Myriogloea sciurus      YES 
Hormosira banksii HIGH    YES YES 
Phyllospora comosa MED     YES 
Solieria robusta      YES 
Ulva sp.#  YES YES YES YES YES 
# Species name withheld 
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Fig. 1 The distribution of published research effort in terms of reference to macroalgae and each of 
the health application terminologies (e.g. anti-inflammatory) as found in Google Scholar database 
of scientific literature. 
 




Fig. 2 Multivariate Dimentional Scaling plot comparing similarities of species fatty acids profiles 
(mg.g-1 d.w.). Samples are from triplicate lipid extracts of six Australian native and endemic 
macroalgae. Data is untransformed. 
 


































































Fig. 3 Key differences in fatty acid content (mg.g-1 d.w.) across the six Australian marine 
macroalgae of both total and individual SFA, MUFA and PUFA  




Table 1 Summary of samples collected seasonally from various locations along the South East 
cost of NSW Australia, including species, phylum, order, collection site (latitude & longitude) 
and/or date of harvest or collection. 
♮Fresh samples collected and immediately freeze-dried for species fatty acid profiling; ♭Freeze-
dried sample prepared from frozen voucher sample; #Species name withheld; species maintained in 
culture.  
Table 2 FA composition of six Australian macroalgal species. Data presented as % molar area of 
total FA. Means with different letters are significantly different (p < 0.05). 
AA: arachidonic acid; ALA: alpha-linolenic acid; DHA: docosahexaenoic acid; EPA: 
eicosapentaenoic acid; ETA: eicosatrienoic acid; LA: linoleic acid. 
Table 3 Cytotoxicity and anti-inflammatory activity (via inhibition of nitric oxide (NO)) of 18 
algal extracts from six macroalgae. Data are presented as % activity at 100 μg.mL-1 from two 
independent trials done in duplicate. 
 
Key: (-) 0 - 24% activity; (+) 25 - 50%; (++) 51 - 75%; (+++) 76 - 100% activity; (nt); not tested, 
no available extract. Investigated cell lines include human pancreatic carcinoma (MIA-PaCa-2), 
Abelson murine leukemia virus-induced tumor macrophage (RAW 264.7) and wild-type murine 
embryo fibroblasts cell lines (WT-MEF)  
 
Table 4 Summary of key differences from the screening process of six taxa of Australian 
macroalgae for prioritizing future work towards anti-inflammatory applications with a focus on 
PUFA content .  
 
# Species name withheld 
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